Celldex Therapeutics shares owned by ALPS Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by ALPS Advisors
from 13F filings
Historical chart of ALPS Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by ALPS Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.7M | 51k | 33.99 |
| 2024-03-31 | $1.9M | 45k | 41.97 |
| 2023-12-31 | $1.5M | 38k | 39.66 |
| 2023-09-30 | $959k | 35k | 27.52 |
| 2023-06-30 | $1.2M | 35k | 33.93 |
| 2023-03-31 | $1.1M | 31k | 35.98 |
| 2022-12-31 | $1.4M | 32k | 44.57 |
| 2022-09-30 | $718k | 26k | 28.09 |
| 2022-06-30 | $748k | 28k | 26.96 |
| 2021-03-31 | $1.5M | 72k | 20.61 |
| 2020-12-31 | $1.2M | 71k | 17.52 |